Bahrain approves Sinopharm vaccine for children aged 3 to 11
Bahrain permits use of the Sinopharm BIBP vaccine for children aged 3 to 11, following review by its Vaccination Committee and approval by the National Medical Taskforce.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthBahrain approves Sinopharm vaccine for children aged 3 to 11
Sign in or subscribeBrowse free archive reportsBahrain permits use of the Sinopharm BIBP vaccine for children aged 3 to 11, following review by its Vaccination Committee and approval by the National Medical Taskforce.